Constitutive Activation and Endocytosis of the Complement Factor 5a Receptor: Evidence for Multiple Activated Conformations of a G Protein‐Coupled Receptor

Serpentine receptors relay hormonal or sensory stimuli to heterotrimeric guanine nucleotide‐binding proteins (G proteins). In most G protein‐coupled receptors (GPCRs), binding of the agonist ligand elicits both stimulation of the G protein and endocytosis of the receptor. We have begun to address whether these responses reflect the same sets of conformational changes in the receptor using constitutively active mutants of the human complement factor 5a receptor (C5aR). Two different mutant receptors both constitutively activate G protein‐mediated responses, but one (F251A) is endocytosed only in response to ligand stimulation, while the other (NQ) is constitutively internalized in the absence of ligand. Both the constitutive and ligand‐dependent endocytosis are accompanied by recruitment of beta‐arrestin to the receptor. An inactivating mutation (N296A) complements the NQ mutation, producing a receptor that is activated only upon exposure to agonist; this revertant receptor (NQ/N296A) is nevertheless constitutively endocytosed. Thus one mutant (F251A) requires agonist for triggering endocytosis but not for activation of the downstream G protein signal, while another (NQ/N296A) behaves in the opposite fashion. Dissociation of two responses normally dependent on agonist binding indicates that the corresponding functions of an activated GPCR reflect different sets of changes in the receptor's conformation.

[1]  E. Zuiderweg,et al.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[3]  M. Caron,et al.  A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation* , 1997, The Journal of Biological Chemistry.

[4]  M. Caron,et al.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.

[5]  J. Demartino,et al.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Marc Parmentier,et al.  Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. , 2002, Molecular biology of the cell.

[7]  R. Lefkowitz,et al.  β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3 , 2000 .

[8]  M. Caron,et al.  Association of β-Arrestin with G Protein-coupled Receptors during Clathrin-mediated Endocytosis Dictates the Profile of Receptor Resensitization* , 1999, The Journal of Biological Chemistry.

[9]  J. Whistler,et al.  Morphine-activated opioid receptors elude desensitization by β-arrestin , 1998 .

[10]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[11]  B. Kobilka,et al.  Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. , 1995, The Journal of biological chemistry.

[12]  L. Hunyady,et al.  Identification of a cytoplasmic Ser-Thr-Leu motif that determines agonist-induced internalization of the AT1 angiotensin receptor. , 1994, The Journal of biological chemistry.

[13]  M. von Zastrow,et al.  Morphine-activated opioid receptors elude desensitization by beta-arrestin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Geffner,et al.  Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. , 1995, Human molecular genetics.

[15]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[16]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[17]  M. Mayer,et al.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones , 1984, Nature.

[18]  J. Köhl,et al.  Site-Directed Mutagenesis of Conserved Charged Residues in the Helical Region of the Human C5a Receptor , 1996 .

[19]  F. Sánchez‐Madrid,et al.  Similarities and Differences in RANTES- and (AOP)-RANTES–triggered Signals: Implications for Chemotaxis , 1999, The Journal of cell biology.

[20]  J. Köhl,et al.  Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. , 1996, European journal of biochemistry.

[21]  Gert Vriend,et al.  GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..

[22]  H. Burger Selective Oestrogen Receptor Modulators , 2000, Hormone Research in Paediatrics.

[23]  C. Strader,et al.  Separation of the structural requirements for agonist-promoted activation and sequestration of the beta-adrenergic receptor. , 1990, Molecular pharmacology.

[24]  M. Caron,et al.  Cellular Trafficking of G Protein-coupled Receptor/β-Arrestin Endocytic Complexes* , 1999, The Journal of Biological Chemistry.

[25]  M. Baggiolini,et al.  The T cell chemokine receptor CCR7 is internalized on stimulation with ELC, but not with SLC , 2001, European journal of immunology.

[26]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[27]  Heidi E. Hamm,et al.  The Many Faces of G Protein Signaling* , 1998, The Journal of Biological Chemistry.

[28]  L. Nowak,et al.  Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.

[29]  Roland L. Dunbrack,et al.  Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.

[30]  T. Kenakin Kenakin replies: Efficacy as the molecular property of a ligand , 1995 .

[31]  T. Kenakin Pharmacological proteus? , 1995, Trends in pharmacological sciences.

[32]  H. Bourne,et al.  Transducin‐alpha C‐terminal mutations prevent activation by rhodopsin: a new assay using recombinant proteins expressed in cultured cells. , 1995, The EMBO journal.

[33]  L. Josefsson,et al.  Evidence for kinship between diverse G-protein coupled receptors. , 1999, Gene.

[34]  T. Schwartz,et al.  Is there a 'lock' for all agonist 'keys' in 7TM receptors? , 1996, Trends in pharmacological sciences.

[35]  Christopher J. Evans,et al.  Morphine Activates Opioid Receptors without Causing Their Rapid Internalization* , 1996, The Journal of Biological Chemistry.

[36]  B. Corvilain,et al.  Somatic and germline mutations of the TSH receptor and thyroid diseases , 2001, Clinical endocrinology.

[37]  M. von Zastrow,et al.  A Phosphorylation-regulated Brake Mechanism Controls the Initial Endocytosis of Opioid Receptors but Is Not Required for Post-endocytic Sorting to Lysosomes* , 2001, The Journal of Biological Chemistry.

[38]  P. Leff,et al.  A three-state receptor model of agonist action. , 1997, Trends in pharmacological sciences.

[39]  R Seifert,et al.  Effects of guanine, inosine, and xanthine nucleotides on beta(2)-adrenergic receptor/G(s) interactions: evidence for multiple receptor conformations. , 1999, Molecular pharmacology.

[40]  H. Bourne,et al.  How receptors talk to trimeric G proteins. , 1997, Current opinion in cell biology.

[41]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[42]  J. Benovic,et al.  β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.

[43]  J. R. Erickson,et al.  Edg-2/Vzg-1 Couples to the Yeast Pheromone Response Pathway Selectively in Response to Lysophosphatidic Acid* , 1998, The Journal of Biological Chemistry.

[44]  W. Lim,et al.  Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. , 2000, Science.

[45]  J. Benovic,et al.  Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.

[46]  H. Brühl,et al.  Differential Activation of CC Chemokine Receptors by AOP-RANTES* , 2000, The Journal of Biological Chemistry.

[47]  B. Ozenberger,et al.  Functional coupling of a mammalian somatostatin receptor to the yeast pheromone response pathway , 1995, Molecular and cellular biology.

[48]  M. Caron,et al.  Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  B. J. Knoll,et al.  Partial agonists and G protein-coupled receptor desensitization. , 1999, Trends in pharmacological sciences.

[50]  M. Pausch,et al.  Pharmacological characterization of the rat A2a adenosine receptor functionally coupled to the yeast pheromone response pathway. , 1996, Molecular pharmacology.

[51]  E. Prossnitz,et al.  Arrestin Binding to the G Protein-coupled N-Formyl Peptide Receptor Is Regulated by the Conserved “DRY” Sequence* , 2000, Journal of Biological Chemistry.

[52]  P. Murphy The molecular biology of leukocyte chemoattractant receptors. , 1994, Annual review of immunology.

[53]  U. Gether Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.

[54]  L. Jan,et al.  Functional Dissociation of μ Opioid Receptor Signaling and Endocytosis Implications for the Biology of Opiate Tolerance and Addiction , 1999, Neuron.